Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507247 · ClinicalTrials.gov registry record · Phase 2
Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
A Phase 2 study of Staphylococcus Aureus, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT00507247 is a Phase 2 study of Staphylococcus Aureus that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 11 participants, below the 3,903-participant average among 8 other Staphylococcus Aureus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00507247, a Phase 2 study of Staphylococcus Aureus, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: Evaluate the efficacy and safety of daptomycin given for treatment of catheter-related bloodstream infections due to S. aureus bacteria with or without exchange of the central venous catheter (CVC) over guide wire in comparison with a historical control group of catheter-related S. aureus bacteremia treated with standard therapy (Vancomycin) or other active agents against staph aureus (such as beta-lactam antibiotics).
Conditions Studied
Interventions
- DRUG Daptomycin
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2006-05 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507247
The ClinicalTrials.gov registry entry for NCT00507247 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,903-participant average among 8 other Staphylococcus Aureus trials with a reported enrollment target (100% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Staphylococcus Aureus appearing as the primary indexed condition, and to 1 intervention - of which Daptomycin is the first listed.
NCT00507247 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00507247 about?
NCT00507247 is a clinical study titled "Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus". Primary Objective: Evaluate the efficacy and safety of daptomycin given for treatment of catheter-related bloodstream infections due to S. aureus bacteria with or without exchange of the central venous catheter (CVC) over guide wire in comparison with a historical control group of catheter-related ...
What is the current status of trial NCT00507247?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2006-05. Estimated completion is 2012-09.
What conditions does trial NCT00507247 study?
This clinical trial studies the following conditions: Staphylococcus Aureus.
What interventions are being tested in trial NCT00507247?
The interventions under investigation include: Daptomycin (DRUG).
Who is sponsoring clinical trial NCT00507247?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00507247 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Staphylococcus Aureus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
RECRUITING · Phase 1
-
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
RECRUITING · Phase 1
-
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
RECRUITING · Phase 4
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
COMPLETED
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.